Innovating Vision: Occuity's Newest Patent Brings the Future into Focus
We are pleased to announce a key milestone in Occuity's technology development strategy has been achieved. One of our recent patents,...
Innovating Vision: Occuity's Newest Patent Brings the Future into Focus
AAO Annual Meeting: The US market gets hands-on with PM1 Pachymeter and AX1 Axiometer™
Exciting first results from Occuity ‘SD1’ diabetes screening prototype
Occuity shortlisted for Health Technology Award at the IET Excellence and Innovation Awards
Occuity Partners with Argus Optik as Exclusive Distributor of PM1 Pachymeter in Hungary
Occuity Partners with Designs for Vision as Exclusive Distributor of PM1 Pachymeter in Australasia
Occuity Partners with Laméris as Exclusive Distributor of PM1 Pachymeter
The Future of Myopia Management: Occuity AX1 Axiometer™
Eyes on the Future: Occuity's Vienna Mission
Occuity makes FDA 510 (K) mark submission to sell the PM1 in the United States
Occuity to Showcase the PM1 and AX1 in Vienna to coincide with the 41st ESCRS Congress!
Shareholder Update - A view from the front
Occuity PM1 Clinical Trial Study Reported in Journal Ophthalmic & Physiological Optics (OPO)
Occuity Named Finalist for Hard Tech Investment of the Year at UK Business Angels Association
Occuity Recognised as a Top 13 European MedTech Startup to Watch by Sifted (Financial Times)
Monitoring Myopia Progression: Why Axial Length Measurements Are Taking the Lead
Occuity enters Boehringer Ingelheim start-ups acceleration program Synapse Acceleration®
CooperVision Sign Letter of Intent for AX1 Global Distribution
Tech Start-up of the Year...
Occuity becomes the largest MedTech raise ever on crowdfunding platform Seedrs, with £2.85m raise.